We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.69%
2 Financials 6.83%
3 Healthcare 6.42%
4 Industrials 4.98%
5 Consumer Discretionary 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOTZ
7426
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
-384,097
Closed -$2.1M
REVHU
7427
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
-1,834,700
Closed -$18.5M
RCOR
7428
DELISTED
Renovacor, Inc.
RCOR
-38,061
Closed -$379K
FLACU
7429
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
-225,001
Closed -$2.26M
VCKAU
7430
DELISTED
Vickers Vantage Corp. I Unit
VCKAU
-30,000
Closed -$305K
USWS
7431
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
-7,733
Closed -$164K
IGNYU
7432
DELISTED
Ignyte Acquisition Corp. Unit
IGNYU
-12,500
Closed -$125K
LUXAU
7433
DELISTED
Lux Health Tech Acquisition Corp. Units
LUXAU
-250,000
Closed -$2.56M
LMAOU
7434
DELISTED
LMF Acquisition Opportunities Inc. Unit
LMAOU
-32,500
Closed -$336K
CCXI
7435
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
-100,000
Closed -$1.34M
TMPMU
7436
DELISTED
Turmeric Acquisition Corp. Unit
TMPMU
-255,000
Closed -$2.56M
ZY
7437
DELISTED
Zymergen Inc. Common Stock
ZY
-40,791
Closed -$865K
RMO
7438
DELISTED
Romeo Power, Inc.
RMO
-339,428
Closed -$2.76M
MF
7439
DELISTED
Missfresh Limited American Depositary Shares
MF
-4,333
Closed -$1.13M
RCHGU
7440
DELISTED
Recharge Acquisition Corp. Unit
RCHGU
-250,000
Closed -$2.55M
GBT
7441
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
-40,000
Closed -$1.4M
ASAQ.U
7442
DELISTED
Atlantic Avenue Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one warrant
ASAQ.U
-312,500
Closed -$3.18M
NMMCU
7443
DELISTED
North Mountain Merger Corp. Unit
NMMCU
-250,000
Closed -$2.55M
CTXS
7444
PUT
DELISTED
Citrix Systems Inc
CTXS
-4,100
Closed -$481K
USAK
7445
DELISTED
USA Truck Inc
USAK
-15,271
Closed -$245K
PTR
7446
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
-38,637
Closed -$1.89M
ALNA
7447
DELISTED
Allena Pharmaceuticals
ALNA
-187,431
Closed -$244K
AXU
7448
DELISTED
Alexco Resource Corp
AXU
-12,451
Closed -$31K
ETACU
7449
DELISTED
E.Merge Technology Acquisition Corp. Unit
ETACU
-420,500
Closed -$4.26M
SHI
7450
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
-13,883
Closed -$325K

Similar funds

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.